PATENT CLAIM ANALYSIS

Application Number: 15942312
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "293000"]

Abstract:
Methods for treating a subject having a cancerous tumor are disclosed. The methods comprise administering to the subject an effective amount of a non-steroidal selective glucocorticoid receptor modulator (SGRM) and an effective amount of a chemotherapeutic agent. The tumor may be cervical cancer. The SGRM may be a fused azadecalin. In embodiments, the SGRM may be a heteroaryl ketone fused azadecalin or an octahydro fused azadecalin.

Claim (Index 8):
The method of  claim 6 , wherein the fused azadecalin is:

Metadata:
- Claim Count in Document: 24.0
- Percentile: 90.0
- Lexical Diversity: 1.64444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15915477', '15697878', '15236015', '15796443', '13901946']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035154375627906
- 35 USC 102 Novelty (BERT): 0.5709634682631384
- Combined Prediction Score: 0.7802602406328254
- Mean Citation Score: 434.382624
- Max Citation Score: 579.2803
- Similarity Product: 308.8423696937442

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test